Literature DB >> 27034275

Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.

Ryan G Walker1, Tommaso Poggioli1, Lida Katsimpardi1, Sean M Buchanan1, Juhyun Oh1, Sam Wattrus1, Bettina Heidecker1, Yick W Fong1, Lee L Rubin1, Peter Ganz1, Thomas B Thompson1, Amy J Wagers2, Richard T Lee2.   

Abstract

Growth differentiation factor 11 (GDF11) and myostatin (or GDF8) are closely related members of the transforming growth factor β superfamily and are often perceived to serve similar or overlapping roles. Yet, despite commonalities in protein sequence, receptor utilization and signaling, accumulating evidence suggests that these 2 ligands can have distinct functions in many situations. GDF11 is essential for mammalian development and has been suggested to regulate aging of multiple tissues, whereas myostatin is a well-described negative regulator of postnatal skeletal and cardiac muscle mass and modulates metabolic processes. In this review, we discuss the biochemical regulation of GDF11 and myostatin and their functions in the heart, skeletal muscle, and brain. We also highlight recent clinical findings with respect to a potential role for GDF11 and/or myostatin in humans with heart disease. Finally, we address key outstanding questions related to GDF11 and myostatin dynamics and signaling during development, growth, and aging.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  heart disease; ligands; muscle; myocardium

Mesh:

Substances:

Year:  2016        PMID: 27034275      PMCID: PMC4818972          DOI: 10.1161/CIRCRESAHA.116.308391

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  166 in total

1.  The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.

Authors:  Thomas B Thompson; Thomas F Lerch; Robert W Cook; Teresa K Woodruff; Theodore S Jardetzky
Journal:  Dev Cell       Date:  2005-10       Impact factor: 12.270

2.  Frequency of the MSTN Lys(K)-153Arg(R) polymorphism among track & field athletes and swimmers.

Authors:  Sigal Ben-Zaken; Yoav Meckel; Dan Nemet; Moran Rabinovich; Eias Kassem; Alon Eliakim
Journal:  Growth Horm IGF Res       Date:  2015-04-18       Impact factor: 2.372

3.  Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort.

Authors:  M J Seibert; Q L Xue; L P Fried; J D Walston
Journal:  J Am Geriatr Soc       Date:  2001-08       Impact factor: 5.562

4.  GDF11 does not rescue aging-related pathological hypertrophy.

Authors:  Shavonn C Smith; Xiaoxiao Zhang; Xiaoying Zhang; Polina Gross; Timothy Starosta; Sadia Mohsin; Michael Franti; Priyanka Gupta; David Hayes; Maria Myzithras; Julius Kahn; James Tanner; Steven M Weldon; Ashraf Khalil; Xinji Guo; Abdelkarim Sabri; Xiongwen Chen; Scott MacDonnell; Steven R Houser
Journal:  Circ Res       Date:  2015-09-17       Impact factor: 17.367

5.  Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases.

Authors:  Neil M Wolfman; Alexandra C McPherron; William N Pappano; Monique V Davies; Kening Song; Kathleen N Tomkinson; Jill F Wright; Liz Zhao; Suzanne M Sebald; Daniel S Greenspan; Se-Jin Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

6.  Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.

Authors:  Joerg Heineke; Mannix Auger-Messier; Jian Xu; Michelle Sargent; Allen York; Stephen Welle; Jeffery D Molkentin
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

7.  Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.

Authors:  Francesco S Loffredo; Matthew L Steinhauser; Steven M Jay; Joseph Gannon; James R Pancoast; Pratyusha Yalamanchi; Manisha Sinha; Claudia Dall'Osso; Danika Khong; Jennifer L Shadrach; Christine M Miller; Britta S Singer; Alex Stewart; Nikolaos Psychogios; Robert E Gerszten; Adam J Hartigan; Mi-Jeong Kim; Thomas Serwold; Amy J Wagers; Richard T Lee
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

8.  Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury.

Authors:  Yuichi Oshima; Noriyuki Ouchi; Masayuki Shimano; David R Pimentel; Kyriakos N Papanicolaou; Kalyani D Panse; Kunihiro Tsuchida; Enrique Lara-Pezzi; Se-Jin Lee; Kenneth Walsh
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

9.  Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay.

Authors:  H Robert Bergen; Joshua N Farr; Patrick M Vanderboom; Elizabeth J Atkinson; Thomas A White; Ravinder J Singh; Sundeep Khosla; Nathan K LeBrasseur
Journal:  Skelet Muscle       Date:  2015-07-15       Impact factor: 4.912

10.  ALK5-dependent TGF-β signaling is a major determinant of late-stage adult neurogenesis.

Authors:  Yingbo He; Hui Zhang; Andrea Yung; Saul A Villeda; Philipp A Jaeger; Oluwatobi Olayiwola; Nina Fainberg; Tony Wyss-Coray
Journal:  Nat Neurosci       Date:  2014-05-25       Impact factor: 24.884

View more
  77 in total

1.  GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.

Authors:  Marianne Pons; Leonidas G Koniaris; Sharon M Moe; Juan C Gutierrez; Aurora Esquela-Kerscher; Teresa A Zimmers
Journal:  Surgery       Date:  2018-05-03       Impact factor: 3.982

Review 2.  The brain, sirtuins, and ageing.

Authors:  Akiko Satoh; Shin-Ichiro Imai; Leonard Guarente
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 3.  Role of circulating factors in cardiac aging.

Authors:  Antonio Cannatà; Gabriella Marcon; Giovanni Cimmino; Luca Camparini; Giulio Ciucci; Gianfranco Sinagra; Francesco S Loffredo
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  Reduced serum myostatin concentrations associated with genetic muscle disease progression.

Authors:  Peter M Burch; Oksana Pogoryelova; Joe Palandra; Richard Goldstein; Donald Bennett; Lori Fitz; Michela Guglieri; Chiara Marini Bettolo; Volker Straub; Teresinha Evangelista; Hendrik Neubert; Hanns Lochmüller; Carl Morris
Journal:  J Neurol       Date:  2017-01-10       Impact factor: 4.849

5.  Blood-Based Therapies to Combat Aging.

Authors:  Joseph M Castellano
Journal:  Gerontology       Date:  2018-09-07       Impact factor: 5.140

6.  Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy.

Authors:  V K Yang; J E Rush; S Bhasin; A J Wagers; R T Lee
Journal:  J Vet Cardiol       Date:  2019-09-01       Impact factor: 1.701

7.  Analysis of Cre-mediated genetic deletion of Gdf11 in cardiomyocytes of young mice.

Authors:  Jessica Garbern; Amy C Kristl; Vinicius Bassaneze; Ana Vujic; Henk Schoemaker; Rebecca Sereda; Liming Peng; Elisabeth M Ricci-Blair; Jill M Goldstein; Ryan G Walker; Shalender Bhasin; Amy J Wagers; Richard T Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

8.  Growth Differentiation Factor 11 does not Mitigate the Lethal Effects of Total-Abdominal Irradiation.

Authors:  Sara Duhachek-Muggy; Kruttika Bhat; Erina Vlashi; Frank Pajonk
Journal:  Radiat Res       Date:  2017-08-22       Impact factor: 2.841

Review 9.  Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.

Authors:  J Gustav Smith; Robert E Gerszten
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

Review 10.  Disease drivers of aging.

Authors:  Richard J Hodes; Felipe Sierra; Steven N Austad; Elissa Epel; Gretchen N Neigh; Kristine M Erlandson; Marissa J Schafer; Nathan K LeBrasseur; Christopher Wiley; Judith Campisi; Mary E Sehl; Rosario Scalia; Satoru Eguchi; Balakuntalam S Kasinath; Jeffrey B Halter; Harvey Jay Cohen; Wendy Demark-Wahnefried; Tim A Ahles; Nir Barzilai; Arti Hurria; Peter W Hunt
Journal:  Ann N Y Acad Sci       Date:  2016-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.